Home | Business News | CBJ Newsmakers | Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal CBJ Newsmakers RecommendedCN Issues Statement on STB DecisionSilver Mountain Mines Inc. Receives Conditional For Reverse Takeover Transaction With Nevgold Corp.Sandoz Canada launches its 6th biosimilar with Inclunox® and Inclunox® HP (Enoxaparin sodium solution for injection 100 mg/mL and 150 mg/mL (High Potency))
